Tekla Capital Management LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 130 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.5%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$6,291,090
+9.4%
154,2690.0%0.25%
+12.3%
Q1 2023$5,749,606
+6.8%
154,2690.0%0.22%
+7.9%
Q4 2022$5,382,445
-37.7%
154,2690.0%0.20%
-42.5%
Q3 2022$8,633,000
+186.7%
154,269
+165.2%
0.35%
+199.2%
Q2 2022$3,011,000
-28.8%
58,1800.0%0.12%
-20.3%
Q1 2022$4,228,000
-38.5%
58,1800.0%0.15%
-33.0%
Q4 2021$6,879,000
-11.9%
58,1800.0%0.22%
-12.0%
Q3 2021$7,805,000
-17.1%
58,1800.0%0.25%
-18.0%
Q2 2021$9,420,000
+120.7%
58,180
+9.4%
0.31%
+108.2%
Q1 2021$4,268,000
+268.9%
53,180
-3.4%
0.15%
+234.1%
Q2 2020$1,157,000
+71.9%
55,0500.0%0.04%
+46.7%
Q1 2020$673,000
-16.7%
55,0500.0%0.03%
-3.2%
Q4 2019$808,000
+9.9%
55,0500.0%0.03%
-3.1%
Q3 2019$735,000
-70.1%
55,050
-63.4%
0.03%
-68.0%
Q2 2019$2,460,000
-4.2%
150,2900.0%0.10%
-3.8%
Q1 2019$2,567,000
+25.2%
150,2900.0%0.10%
+18.2%
Q4 2018$2,051,000
+4.4%
150,290
+118.9%
0.09%
+23.9%
Q3 2018$1,965,000
-57.1%
68,671
-59.0%
0.07%
-59.2%
Q2 2018$4,580,000
+29.7%
167,3810.0%0.17%
+27.0%
Q1 2018$3,530,000
+687.9%
167,381
+497.8%
0.14%
+705.9%
Q2 2017$448,000
-55.7%
28,000
-61.0%
0.02%
-56.4%
Q1 2017$1,012,000
+7.4%
71,8420.0%0.04%
-2.5%
Q4 2016$942,000
-23.0%
71,8420.0%0.04%
-14.9%
Q3 2016$1,223,000
-34.0%
71,842
-17.3%
0.05%
-38.2%
Q2 2016$1,854,00086,8420.08%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders